Skip to main content
Log in

Recent decisions from the SMC

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Scottish Medicines Consortium. SMC advice: budesonide (Budenofalk); budesonide (Budenofalk) Abbreviated; ceftaroline fosamil (Zinforo); clostridium botulinum toxin A (Dysport); dapagliflozin (Forxiga); glycopyrronium (Seebri Breezhaler); ivacaftor (Kalydeco); vildagliptin (Galvus). Internet Document : 14 Jan 2013. Available from: URL: http://www.scottishmedicines.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Recent decisions from the SMC. PharmacoEcon Outcomes News 670, 11 (2013). https://doi.org/10.1007/s40274-013-0112-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0112-4

Navigation